SMTL ID : 8vf6.1

Crystal structure of Serine/threonine-protein kinase 33 (STK33) Kinase Domain in complex with inhibitor CDD-2211

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

homo-dimer

Ligands

2 x 01: {3-[([1,1'-biphenyl]-2-yl)ethynyl]-1H-indazol-5-yl}[(3R)-3-(dimethylamino)pyrrolidin-1-yl]methanone

01.1: 19 residues within 4Å: Chain A: L.25, G.26, F.30, V.33, A.46, K.48, I.79, M.95, E.96, L.97, C.98, E.99, G.101, E.102, E.145, N.146, M.148, T.167, D.168 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.25, A:V.33, A:I.79 Hydrogen bonds: A:K.48, A:C.98 Water bridges: A:D.168 Salt bridges: A:D.168 01.2: 18 residues within 4Å: Chain B: L.25, G.26, F.30, V.33, A.46, K.48, I.79, M.95, E.96, L.97, C.98, E.99, G.101, E.102, E.145, N.146, M.148, D.168 3 PLIP interactions: 3 interactions with chain B Hydrophobic interactions: B:L.25 Hydrogen bonds: B:C.98 Salt bridges: B:D.168

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ku, A.F. et al., Reversible male contraception by targeted inhibition of serine/threonine kinase 33. Science (2024)

Release Date

2024-06-05

Peptides

Serine/threonine-protein kinase 33: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Serine/threonine-protein kinase 33